Today’s Research Reports on Stocks to Watch: International Flavors & Fragrances and athenahealth
NEW YORK, NY / ACCESSWIRE / May 8, 2018 / Athenahealth shares were skyrocketing on Monday and almost touched the stock’s 52-week high after it was revealed that hedge fund Elliott Management has proposed an unsolicited offer to take the company private. Shares of International Flavors and Fragrances weren’t doing as well as they came crashing down to close over 10%. The company agreed to buy Israeli-based Frutarom for $6.4 billion which many on Wall Street fear is a risky move for the company.
RDI Initiates Coverage on:
International Flavors & Fragrances Inc.
https://rdinvesting.com/news/?ticker=IFF
athenahealth, Inc.
https://rdinvesting.com/news/?ticker=ATHN
International Flavors & Fragrances Inc. shares closed down almost 11% on Monday and hit a new low of $126.08 during intra-day trading. The company announced first quarter 2018 earnings reporting 12% revenue growth, 34% operating income growth, and 12% EPS growth compared to the prior-year period. The company saw its shares plummet despite good results as it agreed to buy rival Frutarom Industries of Israel, for $7.1 billion in a cash and stock deal. The deal will give International Flavors & Fragrances a footing into the natural foods arena. The company will pay Frutarom investors $71.19 a share in cash and 0.249 shares of International Flavors and Fragrances for every Frutarom share that they own. The company believes the acquisition of Frutarom will help it “create a global leader in taste, scent and nutrition.” So why the share price decline? Investors are worried the expensive transaction may not be worth it. Plus according to food analyst Brett Hundley of Vertical Group however, the deal is “expensive and risky.”
Access RDI’s International Flavors & Fragrances Inc. Research Report at:
https://rdinvesting.com/news/?ticker=IFF
athenahealth, Inc. shares closed up 16.39% on about 4.3 million shares traded. The stock saw its shares climb after Paul Singer’s Elliott Management put in an unsolicited all-cash bid for the company that values it at $160 a share. The offer is about a 27% premium to the stock’s closing price of $126.08 a share this past Friday. According to Elliott Management, it has had an “extensive private engagement” with Athenahealth’s management and board during the past year, and believes that athenahealth can’t make the changes it needs while it remains a public company. Athenahealth confirmed that it had received an unsolicited bid from Elliott Management and that it will review it. The hedge fund said, “Unfortunately, we are faced now with the stark reality that athenahealth as a public-company investment, despite all of its promise, has not worked for many years, is not working today and will not work in the future.”
Access RDI’s athenahealth, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ATHN
Our Actionable Research on International Flavors & Fragrances Inc. (NYSE: IFF) and athenahealth, Inc. (NASDAQ: ATHN) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute
SOURCE: RDInvesting.com
ReleaseID: 498907